Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Dagshah, my apologies...was referring to the possibility of Jim Cramer being "XXII"'s boss...not yours in my last post.
What's ironic to me is that Pandolfino got caught doing something IH pumpers do day in/day out...these anonymous sites weren't available when he got caught...now his actions would be viewed as fairly commonplace and much easier to get away with...with much broader audience potential.
Not to mention, Jim Cramer (your boss?) pulls that sort of scam on a much grander scale on a regular basis and nothing ever happens to him...what's up with that? Sorry...I digressed...
If anything, we longs should take some comfort in knowing that Joseph's already been scrutinized by the SEC, probably figures he'll ALWAYS be on the SEC's watch list and will likely keep himself pure as the driven snow from this point forward to avoid any future SEC investigations.
p.s. My earlier thank you was a joke...just sayin'...why don't you moderate a message board if you've had so much to say (4,100 posts???) on so many boards since 2006? Interesting, but odd...
Abbam - I wouldn't read too much into it either (or bother to post about it) if my only association with the stock was seeing it on a momentum day trader blog). Thanks for your input.
I agree...Kev is too actively bashing this stock to only have that little skin in the game. Wish he'd find something better to do with his time...makes me sad for him, actually.
I agree...Kev is too actively bashing this stock to only have that little skin in the game. Wish he'd find something better to do with his time...makes me sad for him, actually.
or it could have been a commercial real estate broker showing the space to the next tenant...
Why does IH show the price at $.89/share? That's definitely not where it was when trading was halted.
Great news for you - YOU DON'T HAVE TO SPECULATE...nor would we take what you would say to heart if you did. Life is short, buddy. Please go find something uplifting and worthwhile to do with your time, for your own sake. Trying to convince XXII longs that they are misguided isn't working so do something that would be more rewarding for you. Sincerely concerned for you-
BTW, do you go by both "JJBHM" and "98040"? Wow! I don't know of anyone else who actively uses 2 member names...doing so TOTALLY makes your credibility quotient diminish...just sayin'...
I can totally understand maintaining a position in ISR but why would you bother to maintain two Investors' Hub member names? Very curious indeed. don't bother trying to explain it to me...I now have you on "ignore", although others may like an explanation....
Interesting...I responded to your earlier post because your member name was "98040", Mercer Island, WA's zip code, as you know. The fact that you are now responding to my post under another member name (JJBHM) is odd and concerning. I now have both of your member names on ignore so no need to respond.
It appears that you are from Mercer Island, WA and ISR is a Washington-based company. Do you know something of substance to support your comment or are you just agreeing with Kevin and wasting our time reading your reply to him? If the former, please share. If the latter, please save us from reading worthless posts.
Kev, I am putting you on ignore...but please find something more worthwhile and rewarding to do than belittling others...time is precious and you are wasting yours on fruitless pursuits. Black bandit has you on ignore and you are wasting the time of the rest of us who are here to learn about Isoray and don't want to be privy to your petty and childish messages.
I think the better question is "Why does Kevin waste so much time during his day insulting others?". Doesn't seem like a very worthwhile or uplifting pursuit. Ever thought about volunteering for a charitable organization or committing random acts of kindness as a substitute for bashing others, given that you seem to have so much free time at your disposal? Just a thought...
Thanks, Strut!
What caused the stock to drop so dramatically after hours? Was there any news or was this caused by more manipulation?
Could delay with commercials be related to a buyout? Easai is savvy...my sense is that they would have aired commercials now (during peak weight loss season) if they were in this for the long-term. Perhaps they are waiting for the next owner to cover the expensive cost of television advertising...
According to the link you posted with regard to Jack's sale, he was only exercising stock options that were scheduled to expire on 1/18/2014. No cause for alarm...I would have exercised them as well.
Credit Suisse's comments would be more concerning had they not increased their holdings by 450% when ARNA's price per share was $7.50 - $8.00. Unless they have decreased their holdings substantially since then I'm not concerned...just a bit bemused.
Yes, and they increased their holdings by 450% when the stock was priced between $7 and $7.50/share as I recall...
Has Michael Murphy provided any commentary re: ARNA lately?
It is both interesting and remarkable to me that ARNA's stock price is now considerably lower than it was after ADCOM but before FDA approval...especially given that many thought Belviq would not be approved. First novel obesity drug, it is now on the market and Arena has a highly regarded and successful marketing partner, coverage for the drug by insurance carriers is increasing, approvals and subsequent sales are expected in other countries in 2014, DTC advertising has begun in the US, but the price is trading below $5/ share. Seems quite fishy to me...especially since VVUS, a company that is hemorrhaging cash, has declining sales of Qysmia and can't find a marketing partner, just got upgraded.
But how much has VVUS made from sales of Qysmia? Nada...
Lost a fair amount based on minimal due diligence and as a result of following your cheer leading in January (my bad). Thanks, but I'm not getting sucked in again. Beginning to think that you selected an actor's face as your ihub photo because you are a hedge funder acting like a retail trader.
GLTA, but be careful.
Sorry, Dude. Was reading your post and responded without meaning to with meaningless drivel (letters my fingers found purely by accident). Didn't even realize I'd done it until I logged on to read this afternoon's board posts. Just getting used to my new IPhone...
Good luck to you and thank you for all of your helpful posts.
Found this on the Schwab site. Interesting article from StreetInsider that reports that DEA classification is slated for April. They also note that Belviq has "yet to catch on with patients". No guff, it hasn't even gone to market yet. They also note that Belviq is a "less effective medication" and quote the same abbreviated statistics that would leave one to beliee that Belviq is substantially inferior to Qsymia.
I'm an ARNA long and question the content of this article and wonder why it was issued at such a critical time for ARNA. Seems to indicate, to me anyway, that scheduling is eminent, because I've grown to distrust Wall Street and "objective" reports such as this one. Anyway, I thought share it, for what it is worth.
Also, does anyone else find it quite odd that the number of shares of ARNA that are shorted is as high as it is, given the number of impending catalysts?
Arena (ARNA), VIVUS (VVUS) Face Uphill Obesity Battle as Costs Play Key Role
6:57 AM ET, 03/21/2013 - Street Insider
Arena Pharma (Nasdaq: ARNA) and VIVUS (Nasdaq: VVUS) are fighting the good fight. For profits.
Since the two received FDA approval for their respective obesity pills, Belviq and Qsymia, respectively, the drugs have yet to catch on with patients. Qsymia prescriptions are down 22 percent from a top hit on February 8th, which Belviq is yet to go on sale in the U.S. until after the DEA classifies its ability to be abused, a decision that is slated for some time in April.
One analyst thinks the sales force behind Qsymia is doing it wrong. Instead of marketing to family practitioners, which write the most prescriptions, the team is marketing to specialists. They are going for patients willing to make a lifestyle change rather than just looking for a quick fix.
Price may also be an issue with Belviq running about $200 per month -- about 48 percent more than Qsymia -- and many are unsure how much of that will be covered by insurance. That makes reimbursement a key driver for both companies moving forward.
Arena's Belviq is also a less-effective medication. Studies into approval had those on Belviq losing 3 percent more of body weight versus a placebo. VIVUS Qsymia showed patients losing 6.7 percent and 8.9 percent of body weight for mid- to high-dose regiments versus a placebo.
Belviq is also indicated more for overweight people with another existing condition related to obesity, such as Type 2 diabetes or high blood pressure. The drugs aren't meant to help those with chronic conditions.
Given that insurers are looking at the medications more as cosmetic rather preventative, the fight for better reimbursement appears to be an uphill battle. Traders are taking notice, with about 30.5 percent of VIVUS float and 27 percent of Arena float being held short at the end of February, both up from prior semi-monthly readings.
VIVUS is flat early Thursday, while Arena is indicated lower.
Yup, and I'm still hoping for that pony I asked Santa Claus for when I was six! $2?!?!?! What a joke!
What I don't understand is why institutions hold 78% of VVUS's outstanding shares. What's up with that?
The market is closed on Monday in observance of MLK's birthday.
Bidwackie, thanks for posts and link. Note the disclaimer in the right hand margin of the CHMP page. Could this mean news would be released later today?
Never seen a w formation goes on forever, however...be careful!
No kidding, Clawmann...I am SOOOO impressed by your class and composure as you moderate this board. THANK YOU!
It appears to me that Jim Cramer and Adam Feurstein are following ARNA...
Sorry to alarm you, but was responding to the fact that he changed his position dramatically by adding 10,000 shares, per the post I responded to.
Sorry for typos...so much for trying to send posts from a handheld.
It makes me concerned that only bought 10,000 shares and that 10,000 sharesl only represents 1/3 of his holdings. Even if he got them at $1.35/share, you'd think he'd own more of the stock if he believed in the company. BTW, I own 14,000 shares myself and intended to go long...am not a shorter or a basher.
I guess the REALLY smart people were walking around Walmart today but will exercise their short options tomorrow when the stock hits $7/share, right?
Why did you exercise the put options today? Why not wait until the stock goes to $7/share. Not so sensible!